Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System

Yang LX, Zhang WY, Shen XJ, Liu MQ, Wu MY, Xiao D

Drug Discov Ther. 2025; 19(1):1-9.

DOI: 10.5582/ddt.2025.01008

Characteristics and patterns of adverse event reports in the Japanese Adverse Drug Event Report database over two decades (2004–2023): Exploring findings on sexes and age groups

Tanaka H, Takigawa M, Ide N, Ishii T

Drug Discov Ther. 2025; 19(1):10-21.

DOI: 10.5582/ddt.2024.01090

A pharmacovigilance study based on the FAERS database focusing on anticoagulant and hormonal drugs that induce vaginal hemorrhage

Li RH, Hu PW, Qian L

Drug Discov Ther. 2025; 19(1):22-28.

DOI: 10.5582/ddt.2024.01071

Efficacy of etanercept biosimilar switching from etanercept reference product, using ultrasound and clinical data in outcomes of real world therapy (ESCORT-NGSK Study)

Sumiyoshi R, Kawashiri SY, Shimizu T, Koga T, Kiya R, Tashiro S, Kawazoe Y, Sato S, Ueki Y, Suzuki T, Tsuboi M, Tada Y, Hidaka T, Takaoka H, Hosogaya N, Yamamoto H, Kawakami A

Drug Discov Ther. 2025; 19(1):29-37.

DOI: 10.5582/ddt.2024.01088

Emulsification-based liposomal formulation of gallic acid and curcumin as potent topical antioxidants

Chantadee T, Chaichit S, Kiattisin K, Poomanee W, Okonogi S, Phumat P

Drug Discov Ther. 2025; 19(1):38-48.

DOI: 10.5582/ddt.2025.01000

Decreased serum calcium levels predict severe complications after initial diagnosis in patients with acute type B aortic dissection: A retrospective cohort study

Meng FZ, Fang L, Zhou J, Zhou YY, Zhao JF, Wang L

Drug Discov Ther. 2025; 19(1):49-57.

DOI: 10.5582/ddt.2025.01002

Isolation and characterization of phosphoglycerate kinase and creatine kinase from bighead carp (Aristichthys nobilis): Potential sources for antitumor agents

Gao Y, Liu WY, Yan Q, Li CL, Gu MK, Bi SX, Zheng WM, Zhu JH, Song LY, Yu RM

Drug Discov Ther. 2025; 19(1):58-67.

DOI: 10.5582/ddt.2025.01003

Imaging and serum antigen levels that influence the treatment and prognosis of cryptococcosis in immuno-competent and immunocompromised patients: A 10-year retrospective study

Su Y, Wang MX, Wang QQ, Hu BJ, Pan J

Drug Discov Ther. 2025; 19(1):68-73.

DOI: 10.5582/ddt.2025.01006

Human gut associated Bacteroides and Akkermansia bacteria exhibit immunostimulatory activity in the silkworm muscle contraction assay

Tabuchi F, Kano C, Hirota T, Kanda T, Sekimizu K, Miyashita A

Drug Discov Ther. 2025; 19(1):74-79.

DOI: 10.5582/ddt.2025.01001

Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain

Hu SS, Lyu D, Gao JJ

Drug Discov Ther. 2025; 19(1):80-82.

DOI: 10.5582/ddt.2025.01010